Literature DB >> 24122206

Association between glutathione S-transferase T1 null genotype and glioma susceptibility: a meta-analysis.

Benping Zhang, Jianjiao Wang, Hongshuang Niu, Yang Li, Fei Yuan, Yu Tian, Fenggang Zhou, Zhen Hao, Yongri Zheng, Qingsong Li, Weizhi Wang.   

Abstract

The relationship between genetic polymorphisms of glutathione S-transferase (GST) and the development of glioma has been investigated in several epidemiologic studies. However, these studies report inconsistent results. In order to get this precise result, a meta-analysis was conducted by calculating the pooled odds ratios (OR) and the 95% confidence intervals (95 % CI). Eleven case-control research studies with a total of 2,416 glioma cases and 4,850 controls were included into this meta-analysis. The combined results based on all studies showed that there was no significant association between the GSTT1 null allele and glioma risk (OR = 1.188, 95% CI = 0.929–1.520, P(heterogeneity) = 0.003, P = 0.170). In the subgroup analysis, the same results were found in our work. There was no risk of publication bias in this meta-analysis. Our results suggest that GSTT1 null genotype was not associated with the increased risk of glioma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24122206     DOI: 10.1007/s13277-013-1276-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  20 in total

1.  Heterogeneity testing in meta-analysis of genome searches.

Authors:  Elias Zintzaras; John P A Ioannidis
Journal:  Genet Epidemiol       Date:  2005-02       Impact factor: 2.135

2.  Comparison of two methods to detect publication bias in meta-analysis.

Authors:  Jaime L Peters; Alex J Sutton; David R Jones; Keith R Abrams; Lesley Rushton
Journal:  JAMA       Date:  2006-02-08       Impact factor: 56.272

3.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

Review 4.  Glutathione transferases.

Authors:  John D Hayes; Jack U Flanagan; Ian R Jowsey
Journal:  Annu Rev Pharmacol Toxicol       Date:  2005       Impact factor: 13.820

Review 5.  Molecular mechanisms of glioma cell migration and invasion.

Authors:  Tim Demuth; Michael E Berens
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

6.  Genetic polymorphisms of GSTs and their association with primary brain tumor incidence.

Authors:  Hatice Pinarbasi; Yavuz Silig; Mustafa Gurelik
Journal:  Cancer Genet Cytogenet       Date:  2005-01-15

7.  Treatment of recurrent high grade astrocytoma; results of a systematic review of 1,415 patients.

Authors:  M Huncharek; J Muscat
Journal:  Anticancer Res       Date:  1998 Mar-Apr       Impact factor: 2.480

Review 8.  Leptotrichia endocarditis: report of two cases from the International Collaboration on Endocarditis (ICE) database and review of previous cases.

Authors:  L B Caram; J P Linefsky; K M Read; D R Murdoch; T Lalani; C W Woods; L B Reller; S S Kanj; M M Premru; S Ryan; M Al-Hegelan; P Y Donnio; C Orezzi; M G Paiva; C Tribouilloy; R Watkin; O Harris; D P Eisen; G R Corey; C H Cabell; C A Petti
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-10-25       Impact factor: 3.267

9.  Genetic polymorphisms in glutathione S-transferase mu and theta, N-acetyltransferase, and CYP1A1 and risk of gliomas.

Authors:  Z Trizna; M de Andrade; A P Kyritsis; K Briggs; V A Levin; J M Bruner; Q Wei; M L Bondy
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1998-06       Impact factor: 4.254

10.  Susceptibility to astrocytoma and meningioma: influence of allelism at glutathione S-transferase (GSTT1 and GSTM1) and cytochrome P-450 (CYP2D6) loci.

Authors:  J Elexpuru-Camiruaga; N Buxton; V Kandula; P S Dias; D Campbell; J McIntosh; J Broome; P Jones; A Inskip; J Alldersea
Journal:  Cancer Res       Date:  1995-10-01       Impact factor: 12.701

View more
  1 in total

1.  Association of glutathione S-transferase T1, M1, and P1 polymorphisms in the breast cancer risk: a meta-analysis.

Authors:  Zhiwang Song; Chuan Shao; Chan Feng; Yonglin Lu; Yong Gao; Chunyan Dong
Journal:  Ther Clin Risk Manag       Date:  2016-05-12       Impact factor: 2.423

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.